Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-188,333
Closed -$14.1M 451
2022
Q4
$14.1M Sell
188,333
-402,380
-68% -$28.7M 0.21% 152
2022
Q3
$38.1M Buy
590,713
+313
+0.1% +$21.7K 0.59% 44
2022
Q2
$40.9M Sell
590,400
-38,667
-6% -$2.87M 0.58% 42
2022
Q1
$48.3M Buy
629,067
+166,802
+36% +$12M 0.57% 43
2021
Q4
$35.4M Buy
462,265
+212,055
+85% +$15.6M 0.39% 81
2021
Q3
$18.5M Sell
250,210
-138,726
-36% -$10.4M 0.21% 139
2021
Q2
$25.9M Buy
388,936
+68,181
+21% +$4.56M 0.27% 98
2021
Q1
$23.9M Buy
320,755
+263,912
+464% +$20M 0.23% 123
2020
Q4
$4.14M Sell
56,843
-319,013
-85% -$22.5M 0.04% 342
2020
Q3
$25M Buy
+375,856
New +$23.8M 0.26% 101

Other funds holding HOLX

Jupiter Asset Management's HOLX Position: Q1 2023 in Review

Jupiter Asset Management sold out of Hologic (HOLX) in Q1 2023, closing a stake of 188,333 shares — an estimated $14.1M sold.

Jupiter Asset Management first reported a position in HOLX in Q3 2020 and held it in 10 quarters. The position peaked at $48.3M in Q1 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

  • Jupiter Asset Management reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
  • Jupiter Asset Management sold 188,333 Hologic shares in Q1 2023, an estimated $14.1M.
  • Jupiter Asset Management first reported a position in Hologic in Q3 2020 and held it in 10 quarters.
  • Jupiter Asset Management's Hologic position peaked at $48.3M in Q1 2022.
  • 708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Jupiter Asset Management's 13F filing for Q1 2023, filed 10 May 2023.